tradingkey.logo

BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists

ReutersFeb 19, 2025 3:53 PM

- Immunitybio Inc IBRX.O:

  • FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGE

  • IMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAM

  • IMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGE

Source text: nBwc1xmZza

Further company coverage: IBRX.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI